Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PREFORMED LINE PRODUCTS COPLPC · Entity 4540 | VP, US Manufacturing | June 10, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PREFORMED LINE PRODUCTS CO
Report date June 10, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, $2 par value per shareSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-06-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-10 · Exercise / conversion · Acquired 1,000 · Balance 1,000 F1: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. Row 2 · 2026-06-10 · Disposition to issuer · Disposed 1,000 · Balance 0 |
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $132.40 | Direct | 3,750 |
Reported balance
After 2026-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-10 · Exercise / conversion · Disposed 1,000 · Balance 3,750 F1: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. |
| Restricted stock unitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 681 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 681 F2: Restricted stock units vest 3 years from the date of grant. |
| Restricted stock unitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 407 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 407 F2: Restricted stock units vest 3 years from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.
F2: Restricted stock units vest 3 years from the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 10, 2026 16:42 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 1,000 | $132.40 Strike: $132.40 | $132,400.00 |
DisclosureSEC source: 0002052614-26-000007 · wk-form4_1781109735.xml · derivative · entry 3 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Shares, $2 par value per share · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. F1 · derivative.expiration_date: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. Read SEC document |
| June 10, 2026 Filed Jun 10, 2026 16:42 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Disposition to issuerCommon Shares, $2 par value per share | 1,000 | $360.91 | $360,910.00 |
DisclosureSEC source: 0002052614-26-000007 · wk-form4_1781109735.xml · nonDerivative · entry 2 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 10, 2026 Filed Jun 10, 2026 16:42 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionCommon Shares, $2 par value per share | 1,000 | $132.40 | $132,400.00 |
DisclosureSEC source: 0002052614-26-000007 · wk-form4_1781109735.xml · nonDerivative · entry 1 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. Read SEC document |
| March 10, 2026 Filed Mar 13, 2026 20:51 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 1,750 | $132.40 Strike: $132.40 | $231,700.00 |
DisclosureSEC source: 0002052614-26-000005 · wk-form4_1773435080.xml · derivative · entry 3 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,750 Underlying: Common Shares, $2 par value per share · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. F1 · derivative.expiration_date: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. Read SEC document |
| March 10, 2026 Filed Mar 13, 2026 20:51 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Disposition to issuerCommon Shares, $2 par value per share | 1,750 | $260.34 | $455,595.00 |
DisclosureSEC source: 0002052614-26-000005 · wk-form4_1773435080.xml · nonDerivative · entry 2 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 10, 2026 Filed Mar 13, 2026 20:51 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionCommon Shares, $2 par value per share | 1,750 | $132.40 | $231,700.00 |
DisclosureSEC source: 0002052614-26-000005 · wk-form4_1773435080.xml · nonDerivative · entry 1 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 22:28 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | GrantRestricted stock units · Derivative | 407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002052614-26-000002 · wk-form4_1770416896.xml · derivative · entry 1 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 407 Underlying: Common shares, $2 par value · 407 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units converted into common stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted stock units vest 3 years from the date of grant. F2 · derivative.expiration_date: Restricted stock units vest 3 years from the date of grant. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 21:02 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 1,000 | $132.40 Strike: $132.40 | $132,400.00 |
DisclosureSEC source: 0002052614-25-000005 · wk-form4_1765573356.xml · derivative · entry 3 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Shares, $2 par value per share · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. F1 · derivative.exercise_date: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. F1 · derivative.expiration_date: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 21:02 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Disposition to issuerCommon Shares, $2 par value per share | 1,000 | $207.23 | $207,230.00 |
DisclosureSEC source: 0002052614-25-000005 · wk-form4_1765573356.xml · nonDerivative · entry 2 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 21:02 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionCommon Shares, $2 par value per share | 1,000 | $132.40 | $132,400.00 |
DisclosureSEC source: 0002052614-25-000005 · wk-form4_1765573356.xml · nonDerivative · entry 1 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date. Read SEC document |
| August 04, 2025 Filed Aug 11, 2025 14:44 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 625 | $61.24 Strike: $0.00 | $38,275.00 |
DisclosureSEC source: 0002052614-25-000003 · wk-form4_1754923446.xml · derivative · entry 3 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, $2 par value per share · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 19, 2022, the reporting person was granted 2,500 stock options, of which 1,250 vested on July 19, 2023, 625 vested on July 19, 2024, and the remaining 625 vested on July 19, 2025. This transaction refers to the exercise of the last vested tranche of 625 shares at the option strike price. F1 · derivative.exercise_date: On July 19, 2022, the reporting person was granted 2,500 stock options, of which 1,250 vested on July 19, 2023, 625 vested on July 19, 2024, and the remaining 625 vested on July 19, 2025. This transaction refers to the exercise of the last vested tranche of 625 shares at the option strike price. F1 · derivative.expiration_date: On July 19, 2022, the reporting person was granted 2,500 stock options, of which 1,250 vested on July 19, 2023, 625 vested on July 19, 2024, and the remaining 625 vested on July 19, 2025. This transaction refers to the exercise of the last vested tranche of 625 shares at the option strike price. Read SEC document |
| August 04, 2025 Filed Aug 11, 2025 14:44 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Disposition to issuerCommon Shares, $2 par value per share | 625 | $154.28 | $96,425.00 |
DisclosureSEC source: 0002052614-25-000003 · wk-form4_1754923446.xml · nonDerivative · entry 2 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 04, 2025 Filed Aug 11, 2025 14:44 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | Exercise / conversionCommon Shares, $2 par value per share | 625 | $61.24 | $38,275.00 |
DisclosureSEC source: 0002052614-25-000003 · wk-form4_1754923446.xml · nonDerivative · entry 1 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 19, 2022, the reporting person was granted 2,500 stock options, of which 1,250 vested on July 19, 2023, 625 vested on July 19, 2024, and the remaining 625 vested on July 19, 2025. This transaction refers to the exercise of the last vested tranche of 625 shares at the option strike price. Read SEC document |
| February 05, 2025 Filed Mar 5, 2025 17:47 UTC | PREFORMED LINE PRODUCTS CO PLPC · Entity 4540 | GrantRestricted stock units · Derivative | 681 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010327 · wk-form4_1741196833.xml · derivative · entry 1 Morcos Assaad A · CIK 0002052614 · VP, US Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 681 Underlying: Common shares, $2 par value · 681 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units converted into common stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted stock units vest 3 years from the date of grant. F2 · derivative.expiration_date: Restricted stock units vest 3 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.